1. Home
  2. CLDX vs IGIC Comparison

CLDX vs IGIC Comparison

Compare CLDX & IGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • IGIC
  • Stock Information
  • Founded
  • CLDX N/A
  • IGIC 2001
  • Country
  • CLDX United States
  • IGIC Jordan
  • Employees
  • CLDX N/A
  • IGIC N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • IGIC Property-Casualty Insurers
  • Sector
  • CLDX Health Care
  • IGIC Finance
  • Exchange
  • CLDX Nasdaq
  • IGIC Nasdaq
  • Market Cap
  • CLDX 1.3B
  • IGIC 1.0B
  • IPO Year
  • CLDX 2008
  • IGIC N/A
  • Fundamental
  • Price
  • CLDX $21.35
  • IGIC $23.12
  • Analyst Decision
  • CLDX Buy
  • IGIC Buy
  • Analyst Count
  • CLDX 9
  • IGIC 2
  • Target Price
  • CLDX $50.00
  • IGIC $31.50
  • AVG Volume (30 Days)
  • CLDX 1.0M
  • IGIC 137.6K
  • Earning Date
  • CLDX 08-07-2025
  • IGIC 05-06-2025
  • Dividend Yield
  • CLDX N/A
  • IGIC 7.91%
  • EPS Growth
  • CLDX N/A
  • IGIC 1.83
  • EPS
  • CLDX N/A
  • IGIC 2.73
  • Revenue
  • CLDX $7,559,000.00
  • IGIC $537,909,000.00
  • Revenue This Year
  • CLDX N/A
  • IGIC $6.05
  • Revenue Next Year
  • CLDX N/A
  • IGIC $7.01
  • P/E Ratio
  • CLDX N/A
  • IGIC $8.46
  • Revenue Growth
  • CLDX 24.49
  • IGIC 5.21
  • 52 Week Low
  • CLDX $14.40
  • IGIC $13.82
  • 52 Week High
  • CLDX $47.00
  • IGIC $27.76
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 59.74
  • IGIC 45.15
  • Support Level
  • CLDX $19.25
  • IGIC $22.63
  • Resistance Level
  • CLDX $20.56
  • IGIC $23.67
  • Average True Range (ATR)
  • CLDX 1.13
  • IGIC 0.47
  • MACD
  • CLDX 0.04
  • IGIC 0.01
  • Stochastic Oscillator
  • CLDX 97.22
  • IGIC 36.18

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

Share on Social Networks: